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Abstract
Human natural killer-1 (HNK-1) carbohydrate (HSO3-3GlcAβ1-3Galβ1-4GlcNAc-R) is highly
expressed in the brain and required for learning and neural plasticity. We previously demon-
strated that expression of the HNK-1 epitope is mostly abolished in knockout mice for GlcAT-P
(B3gat1), a major glucuronyltransferase required for HNK-1 biosynthesis, but remained in spe-
cific regions such as perineuronal nets (PNNs) in these mutant mice. Considering PNNs are
mainly composed of chondroitin sulfate proteoglycans (CSPGs) and regulate neural plasticity,
GlcAT-P-independent expression of HNK-1 in PNNs is suggested to play a role in neural plas-
ticity. However, the function, structure, carrier glycoprotein and biosynthetic pathway for
GlcAT-P-irrelevant HNK-1 epitope remain unclear. In this study, we identified a unique HNK-1
structure on aggrecan in PNNs. To determine the biosynthetic pathway for the novel HNK-1,
we generated knockout mice for GlcAT-S (B3gat2), the other glucuronyltransferase required
for HNK-1 biosynthesis. However, GlcAT-P and GlcAT-S double-knockout mice did not exhibit
reduced HNK-1 expression compared with single GlcAT-P-knockout mice, indicating an
unusual biosynthetic pathway for the HNK-1 epitope in PNNs. Aggrecan was purified from cul-
tured cells in which GlcAT-P and -S are not expressed and we determined the structure of the
novel HNK-1 epitope using liquid chromatography/mass spectrometry (LC/MS) as a sulfated
linkage region of glycosaminoglycans (GAGs), HSO3-GlcA-Gal-Gal-Xyl-R. Taken together, we
propose a hypothetical model where GlcAT-I, the sole glucuronyltransferase required for syn-
thesis of the GAG linkage, is also responsible for biosynthesis of the novel HNK-1 on aggrecan.
These results could lead to discovery of new roles of the HNK-1 epitope in neural plasticity.
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Introduction
The extracellular matrix (ECM) plays vital roles in various physiological phenomena occurring
in the central nervous system (CNS) [1–4]. In particular, perineuronal nets (PNNs), a special-
ized ECM structure surrounding neuronal cell bodies and proximal dendrites in the CNS, regu-
late neural plasticity [5, 6]. PNNs are composed of hyaluronan, chondroitin sulfate
proteoglycans (CSPGs), link protein and tenascin-R [5–9] and ensheath parvalbumin (PV)-
positive gamma-aminobutyric acid (GABA)-ergic interneurons and some pyramidal neurons
[10–14]. Timing of PNN formation corresponds to the end of the critical period during which
synaptogenesis, synaptic refinement and maturation of the nervous system occur [15–18], sug-
gesting that formation of PNNs depends on completion or fixation of plastic change in neural
activity. Previous reports demonstrated that cats reared in the dark with less sensory input
showed delay in both the closure of the critical period and the emergence of PNNs in their
brains [19, 20]. Additionally, sensory deprivation of whisker or facial vibrissae reduced the
number of PNNs in rodent somatosensory cortex [21, 22]. These data strongly suggest that
activity-dependent formation of PNNs has an important role in the regulation of neural
plasticity.
Digestion of the chondroitin sulfate (CS) chain on CSPGs, a major component of PNNs,
resulted in the reactivation of ocular dominance plasticity in adult mice [16]. Additionally,
transgenic mice overexpressing chondroitin 6-sulfotransferase-1 (C6ST-1), a sulfotransferase
involved in the 6-O-sulfation of GalNAc residues of the repeating disaccharide units in the CS
chain, exhibited persistent ocular dominant plasticity in the adult brain, probably due to abnor-
mal PNN morphology [23]. These data indicate that CSPGs, especially their CS chains, criti-
cally regulate neural plasticity in PNNs, but the detailed molecular mechanisms underlying the
CS-dependent neural plasticity remain unclear.
To visualize PNNs, several monoclonal antibodies have been used; e.g., human natural
killer-1 (HNK-1), 4F4 [24], VC1.1 [25] and Cat-315 [26], all of which react with the HNK-1
carbohydrate epitope, suggesting that the HNK-1 carbohydrate is involved in neural plasticity
as a PNN component. The HNK-1 epitope is highly expressed in the CNS and its unique struc-
ture was determined to be a sulfated trisaccharide, HSO3-3GlcAβ1-3Galβ1-4GlcNAc-R [27].
We cloned and characterized two glucuronyltransferases (GlcAT-P and GlcAT-S) and a sulfo-
transferase (HNK-1ST) as key enzymes responsible for HNK-1 biosynthesis [28–30]. We also
demonstrated that GlcAT-P-knockout (PKO) mice show a significant decrease in the HNK-1
epitope, resulting in reduced long-term potentiation (LTP) at the hippocampal CA1 region
and impaired spatial learning [31]. These phenotypes are likely due to impairments in spine
maturation and in cell surface retention of glutamate receptors in developing brains [32], indi-
cating that the HNK-1 carbohydrate synthesized by GlcAT-P is required for the proper func-
tion of the mammalian CNS. Although HNK-1 monoclonal antibody (mAb)
immunoreactivity was mostly abolished in the PKO mouse brain, some HNK-1 epitopes
remained in the PNNs that co-localized with the lectinWisteria floribunda agglutinin (WFA),
another well-established PNNmarker [31]. These results suggest that the HNK-1 epitope
expressed in PNNs is synthesized by another glucuronyltransferase involved in neural plasticity
such as GlcAT-S; however, its function, carrier protein and structure remain unclear.
In this study, we first explored a carrier protein of the GlcAT-P-irrelevant HNK-1 in PNNs
and identified aggrecan. To examine its biosynthetic pathway, we generated GlcAT-S-knockout
(SKO) mice as well as GlcAT-P and GlcAT-S double-knockout (DKO) mice and revealed that
GlcAT-S is not responsible for its biosynthesis. Furthermore, using liquid chromatography/
mass spectrometry (LC/MS) analysis, we found that a unique linkage region of the HNK-1
structure (HSO3-GlcA-Gal-Gal-Xyl-R) is expressed on aggrecan, which is likely synthesized by
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GlcAT-I but not by GlcAT-P and -S. Our study highlights new aspects of the HNK-1 epitope
in PNNs.
Materials and Methods
Protein extraction frommouse brains
All the animal experiments were conducted according to the Fundamental Guidelines for
Proper Conduct of Animal Experiments and Related Activities in Academic Research Institu-
tions under the jurisdiction of the Ministry of Education, Culture, Sports, Science and Technol-
ogy of Japan and approved by the Committees on Animal Experimentation of University of
Tsukuba and Kyoto University. Whole brains dissected from 2- or 6-week-old mice were
homogenized with 4 volumes of homogenizing buffer (20 mM Tris-HCl (pH 7.4) containing
150 mMNaCl, 1 mM EDTA and protease inhibitors (Nacalai Tesque)). The homogenates
were centrifuged at 1,000 × g for 10 min to remove nuclei, followed by centrifugation at
105,000 × g for 60 min. The supernatants produced the Tris-buffered saline (TBS) soluble frac-
tions. The pellets were rehomogenized with urea-containing buffer (10 mM Tris-HCl (pH7.4)
containing 1 mM EDTA and 6 M urea) and then the homogenates were centrifuged at
105,000 × g for 60 min. The resulting supernatants were the urea-soluble fractions. The urea-
and TBS-soluble fractions were combined and used as soluble fractions.
Glycosidase digestion
Soluble fraction proteins (30 μg) from mouse brains were precipitated with ethanol and sus-
pended with 20 to 50 μl of chondroitinase buffer (10 mM Tris-HCl (pH7.4), 30 mM sodium
acetate, 50 mM EDTA and protease inhibitors), followed by incubation with a final concentra-
tion of 250 μU/ml of chondroitinase ABC (chABC) (Seikagaku Corporation) for 3 h at 37°C.
The reaction mixtures were denatured with 0.5% sodium dodecyl sulfate (SDS) for 5 min at
100°C. To reduce the SDS concentration, the solution was diluted with 4 volumes of phos-
phate-buffered saline (PBS) containing 25 mM EDTA, 1.25% NP-40 and 1.25% 2-mercap-
toethanol. Peptide N-glycosidase F (PNGase F, Roche Applied Science) was added at the final
concentration of 20 mU/μl, followed by incubation for 16 h at 37°C.
SDS-PAGE and western blotting
Proteins were separated in 3–10% gradient or 7% polyacrylamide gels and transferred to nitro-
cellulose membranes. After blocking with 5% nonfat dry milk in PBS containing 0.05% Tween
20, the membranes were incubated with primary antibodies, followed by horseradish peroxi-
dase (HRP)-conjugated secondary antibodies. Protein bands were detected using Super Signal
West Pico chemiluminescence reagent (Thermo Fisher Scientific), and the signal intensities
were quantified using Image Gauge software (FUJIFILM). The following primary antibodies
were used: HNK-1 monoclonal antibody (mAb) (a hybridoma cell line purchased from Ameri-
can Type Culture Collection, final concentration 4 μg/ml), M6749 mAb (kindly provided by
Dr. H. Tanaka, Kumamoto University, final concentration 4 μg/ml), 6B4 mAb (developed as
described previously [33], final concentration 4 μg/ml), Cat-315 mAb (Millipore, 1:500), anti-
aggrecan polyclonal antibody (pAb) (Millipore, 1:500), anti-phosphacan pAb (antiserum was
raised in rabbits against recombinant full-length phosphacan, which was expressed in and
purified from COS-1 cells, final concentration 3.4 μg/ml), anti-NCAMmAb (kindly provided
by Dr. K. Ono, Kyoto Prefectural University, clone H28, final concentration 0.7 μg/ml), anti-
actin mAb (Millipore, 1:1000), anti-Fc pAb (Jackson ImmunoResearch, 1:1000), CS56 mAb
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(Sigma, 1:250) and anti-chondroitin sulfate A mAb (Seikagaku Corporation, clone IIH6,
1:250).
Immunoprecipitation
Soluble fractions (600 μg) from mouse brains (PKO and DKO) were dialyzed against TBS
using Slide-A-Lyzer Dialysis Cassette (Thermo Fisher Scientific) or precipitated with ethanol.
After dialysis or ethanol-precipitation, proteins were suspended with 50 μl of chondroitinase
buffer, followed by incubation with a final concentration of 250 μU/ml of chABC for 3 h at
37°C. The reaction mixtures were denatured with 0.5% SDS for 3 min at 100°C. To reduce the
SDS concentration, the solution was diluted with 4 volumes of TBS containing 1% Triton X-
100, followed by incubation with anti-aggrecan antibody (8 μg/ml final concentration), anti-
phosphacan antibody (15 μg/ml final concentration) or normal rabbit IgG (Santa Cruz, 4 μg/
ml final concentration) for 30 min at 4°C. The mixtures were then incubated with Protein G
Sepharose (GE Healthcare) O/N at 4°C with gentle shaking. The beads were washed extensively
with TBS containing 0.1% Triton X-100 and bound proteins were eluted by boiling in Laemmli
sample buffer.
Immunohistochemistry
Mice were deeply anesthetized and transcardially perfused with PBS and subsequently with
PBS containing 4% paraformaldehyde. After cryoprotection with 30% sucrose, the tissues were
sliced in 40-μm-thick sections using a microtome. Free-floating sections were incubated with
5 μg/ml primary antibodies (HNK-1 mAb, 6B4 mAb, Cat-315 mAb and aggrecan pAb) or bio-
tinylated WFA lectin (Sigma, 1:400) diluted with PBS containing 3% bovine serum albumin for
2 h at room temperature, followed by incubation with Alexa Fluor conjugated secondary anti-
bodies (Molecular Probes, 1:400) or Fluorescein AvidinD (VECTOR Laboratories, 1:400) for 1
h at room temperature. Sections were visualized under a Fluoview laser confocal microscope
system, FV1000-D IX81 (Olympus).
GlcAT-P (B3gat1) and GlcAT-S (B3gat2) deficient mice
The method for generation of GlcAT-P gene (B3gat1)-deficient mice (PKO) was described pre-
viously [31]. GlcAT-S (B3gat2) gene-deficient mice (SKO) were produced as follows: genomic
clone λ1011 harboring the exon1 of murine GlcAT-S, containing the initiation codon and
transmembrane region was isolated from a murine 129/SvJλphage library [34]. Construction of
the targeting vector is schematically represented in Fig 1A. A 5’ fragment (5.7 kb) containing a
part of exon1 and 5’-end region and isolated by digestion using XbaI and BamHI was sub-
cloned into pBluescript II SK(+) (pBS). A 3’ fragment (1.1 kb), a portion of the intron between
exon1 and exon2, was digested with SpeI and HindIII, rendered blunt using Klenow enzyme
and cloned into the EcoRV site of pBS. pCH110 (a gift from Dr. M. Asano, Kanazawa Univer-
sity) was digested with HindIII and BamHI and the β-galactosidase gene (3.7-kb fragment
released) was religated with the vector containing the 5’ fragment. The neomycin resistance
gene cassette in the vector pPGKneobpA [35] and the diphtheria toxin A (DT-A) gene cassette
in vector pMC1DT-A [36] were introduced into the vector containing the 3’ fragment as posi-
tive and negative selection makers, respectively. The resulting plasmid was digested with NotI
and ApaI, religated with the vector containing the 5’ fragment and β-galactosidase. The con-
structed targeting vector was transfected into ES cells and positive selection was performed
using G418 (GIBCO). ES clones possessing the targeting allele from homologous recombina-
tion were selected using PCR and genome DNA was isolated from positive clones and analyzed
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using Southern blotting (Fig 1B). Targeting cell clones were injected into C57BL/6 blastocysts
to obtain chimeric mice.
Protein extraction frommouse kidney
Kidneys from 6-week-old wild-type (WT), GlcAT-S hetero (+/-) and homo (-/-) knockout
mice were homogenized in 9 volumes of 20 mM Tris-HCl (pH 7.5) containing 150 mMNaCl,
1 mM EDTA and protease inhibitors at 4°C. The homogenates were centrifuged at 1,000 × g
for 10 min at 4°C to remove nuclei. The supernatants were centrifuged at 105,000 × g for 1 h at
4°C. The resulting precipitates were used as membrane fractions.
cDNA construction
Expression plasmid of aggrecan-Fc was constructed as follows. Two separate PCR reactions
were performed to generate two overlapping gene fragments predicted to encode signal pep-
tide, G1, CS2 and G3 domains (mini aggrecan) using human aggrecan cDNA obtained from
Fig 1. Generation of GlcAT-S-deficient mice. (A) Schematic diagram of the targeting construct. For
targeted disruption of the mouse GlcAT-S gene (B3gat2), exon1 containing the initiation codon and
transmembrane region were replaced with a neo/lacZ cassette. Hatched lines represent the fragments used
for the construction of the targeting vector. PCR primers used for screening are shown in arrowheads. Black
bars indicate probes for Southern blot analysis. (B) Southern blot analysis of targeted ES cell clones.
Genomic DNA isolated from ES cell clones were digested with PstI or SpeI and EcoRV, blotted and then
hybridized with the 3’ or 5’ probe, respectively. The expected sizes of theWT allele and targeted allele (KO)
are indicated. The ES clones, 6, 29, 37, 62, 116, 127, 203 and 258 were positive when screening using PCR.
ES clone 115 was used as a negative control. (C) Western blot analysis of SKOmice. The membrane
proteins were prepared from 6-week-old mouse kidneys (WT; +/+, heterozygote; +/-, homozygote; -/-). A non-
sulfated form of HNK-1 epitope was detected with M6749 mAb.
doi:10.1371/journal.pone.0144560.g001
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the DNAFORM as a template. In the first PCR, the cDNA fragment containing signal peptide
and G1 domain was amplified using a 5’-primer (5’- CGGGATCCGTCCAACTCTTCAAGGT
GAACT-3’) containing an in-frame BamHI site (underlined) and a 3’-primer (5’-AAAGTCAG
GCAGGCCTGTGTAGCAGATGGC-3’). In the second round of PCR, the cDNA fragment
containing CS2 and G3 domains was amplified using a 5’-primer (5’-GCCATCTGCTACACA
GGCCTGCCTGACTTT-3’) and a 3’-primer (5’-CGGGATCCGTGGGCTGTGCTGGGGCG
GCT-3’) containing an in-frame BamHI site (underlined). The two PCR products were gel-
purified and used as a template for a third PCR reaction containing the 5’-primer (5’- CGGGA
TCCGTCCAACTCTTCAAGGTGAACT-3’) containing an in-frame BamHI site and the
3’-primer (5’-CGGGATCCGTGGGCTGTGCTGGGGCGGCT-3’) containing an in-frame
BamHI site. The final PCR fragment was digested with BamHI and ligated into pcDNA3.1-
myc/His vector (Invitrogen) predigested with BamHI to obtain pcDNA3.1/mini aggrecan. The
subcloning of the mini aggrecan into pEF-Fc mammalian expression vector was performed as
follows: to insert a splicing donor signal, a cDNA fragment encoding a C-terminal region of
aggrecan was amplified using PCR with a sense primer 5’-GCATCTAGAAATTGAGTCCTCA
AG-3’ (endogenous XbaI site, underlined) and an antisense primer 5’-CCGTCTAGAGGAT
CCACTCACCGTGGGCTGTGCTGGGGCGGCTCCT-3’ (XbaI site, BamHI site and a splic-
ing donor signal GTGAGT, underlined) using pcDNA3.1/mini aggrecan as a template. After
digestion with XbaI, the product was ligated into pcDNA3.1/mini aggrecan previously digested
with XbaI. Subsequently, the resultant plasmid was digested with BamHI and the aggrecan
fragment was ligated into the pEF-Fc empty vector previously digested with BamHI. Expres-
sion plasmid of phosphacan-myc-Fc, myc-Fc-tagged full-length rat phosphacan, was described
previously [37].
Cell culture and transfection
COS-1 cells were purchased from American Type Culture Collection (ATCC CRL-1650).
COS-1 cells were maintained in Dulbecco’s modified Eagle’s medium supplemented with 10%
fetal bovine serum at 37°C until 50–70% confluency. For transfection, cells were plated on
175-cm2 culture flasks. Cells were transfected with the expression plasmids using X-treme-
GENE HP DNA Transfection Reagent (Roche Applied Science) according to the manufactur-
er’s protocol. After 5–6 h of transfection, the culture medium was replaced with Ajinomoto
serum-free Medium 104 (Ajinomoto). Cells were incubated for an additional 3 days to produce
culture medium containing secreted proteins.
Purification of recombinant aggrecan-Fc
Recombinant aggrecan-Fc was purified from the culture medium using Protein G Sepharose
and eluted with 50 mM diethylamine pH 11.5 containing 150 mMNaCl. The eluate was imme-
diately neutralized with 0.5 M NaH2PO4.
Quantification of chondroitin sulfate
The purified recombinant aggrecan-Fc was subjected to gel filtration on a PD-10 column (GE
Healthcare). The flow-through fractions were collected and digested with 5 mIU of chABC
(Seikagaku Corporation) in 60 mM sodium acetate, 50 mM Tris-HCl (pH 8.0) for 12 h at 37°C.
The digests were derivatized with a fluorophore, 2-aminobenzamide, and then analyzed by
anion-exchange high-performance liquid chromatography (SLC-10A, Shimadzu) on a PA-03
column (YMC). Identification and quantification of the resulting disaccharides were achieved
by comparison with chondroitin sulfate-derived authentic unsaturated disaccharides (Seika-
gaku Corporation), as described previously [38].
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LC/MS glycan analysis
The purified recombinant aggrecan-Fc treated with chABC and PNGase F to remove chon-
droitin sulfate and N-glycans was precipitated with ethanol and then lyophilized. O-glycans
were released by hydrazinolysis and pyridylaminated according to a procedure described pre-
viously [37]. PA-labeled O-linked glycans were separated on a graphitized carbon column
(150 × 0.075 mm, 5 μm; Chemicals Evaluation and Research Institute) at a flow rate of
300 nl/min in a Paradigm MS4 HPLC system (Michrom BioResources). The mobile phases
were 1 mM ammonium acetate containing 2% acetonitrile (A buffer) and 1 mM ammonium
acetate containing 80% acetonitrile (B buffer). The glycans were eluted with a linear gradient
of 2–65% of B buffer for 50 min. MS was performed using an Orbitrap Elite Mass Spectrome-
ter (Thermo Fisher Scientific). The electrospray voltage for MS was -2.5 kV in the negative
ion mode and the collision energy was 25% for the MS/MS and MS/MS/MS experiments.
Mass spectra were acquired by selected ion monitoring (SIM) mode. The resolution was
60,000 and the scan range wasm/z 782.5–832.5.
Results
Aggrecan is an HNK-1 carrier protein in PKOmice
In PKO mouse brain, HNK-1 epitope was mostly abolished except for PNNs, indicating that it
is suitable to analyze PKO mice to characterize HNK-1 carrier protein in PNNs. Previous
reports demonstrated that HNK-1 epitope was expressed on aggrecan in the adult mouse brain
[39] and especially in PNNs [26, 40]. Therefore, we examined whether the carrier protein of
GlcAT-P-irrelevant HNK-1 epitope was also aggrecan or not.
To characterize the carrier protein of the HNK-1 epitope in PNNs in PKO mouse brain,
brain soluble fractions including major PNN components were prepared from 2-week-old
(PNN-unformed) and 6-week-old (PNN-formed) wild type (WT) and PKOmice (Fig 2A).
Consistent with our previous report, all HNK-1 immunoreactive bands detected in WTmice
had disappeared in 2-week-old PKO mice (Fig 2A,HNK-1 panel, lanes 1 to 6) [32, 37], indicat-
ing that GlcAT-P is dominant for HNK-1 synthesis in the developing brain. In contrast, after
PNN formation was completed, a faint smear band over 250 kDa was detected with HNK-1
mAb in 6-week-old PKO mice (Fig 2A, HNK-1 panel, lane 10). Previous reports for the devel-
oping mouse brain showed that an HNK-1 carrying smear protein over 250 kDa was a CSPG,
phosphacan, and was converged after chABC treatment [37, 39, 40, 41] (Fig 2A,HNK-1 panel,
lane 2). This suggests the smear pattern of the band in the 6-week-old PKO mice was also
derived from large CS chains. The molecular weight of the HNK-1-positive band in 6-week-old
PKO mice shifted down after the removal of the CS chain with chABC. (Fig 2A, HNK-1 panel,
lane 11), demonstrating the HNK-1 carrier protein in the 6-week-old PKO mice was a CSPG.
In contrast to N-glycan-linked HNK-1 epitopes on many other HNK-1 carrier proteins such as
GluA2, tenascin-R, NCAM, P0 and MAG in the CNS [32, 42, 43], removal of N-glycans with
PNGase F did not reduce the HNK-1 signal in 6-week-old PKO mice (Fig 2A,HNK-1 panel,
lane 12). This suggests that the HNK-1 epitope attached to the CSPG in 6-week-old PKO mice
is present on a unique core glycan structure. The HNK-1-carrying molecule in 6-week-old
PKO mice was also detected using two other HNK-1-recognizing antibodies, 6B4 and Cat-315
[26, 33, 37, 39, 40, 41] (Fig 2A, 6B4 and Cat-315 panels), and the signals for this protein in
6-week-old WT mice appeared to be stronger than those for the other HNK-1-carrying mole-
cules, which is consistent with the previous report by Dino et al. [39]. This indicates these two
HNK-1-related mAbs react with HNK-1 epitopes with different specificities from HNK-1 mAb
and prefer the unique HNK-1 epitope on CSPG.
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Considering the molecular weights of the PNN component CSPGs (aggrecan, phosphacan,
versican, brevican and neurocan) [5–9], aggrecan and phosphacan were the most feasible
HNK-1 carrier candidates in the 6-week-old PKO mice. To test this possibility, mouse brain
soluble fractions were immunoblotted for phosphacan and aggrecan after chABC and PNGase
F treatment (Fig 2B). The molecular weight of aggrecan was similar to that of HNK-1, which
was minimally affected by digestion with PNGase F in 6-week-old PKO mice (Fig 2B, aggrecan
panel, lane 12 and HNK-1 panel). In contrast, the molecular weight of phosphacan and its
larger downshift after PNGase F digestion were different from HNK-1 (Fig 2B, phosphacan
Fig 2. HNK-1 carbohydrate epitope expressed in GlcAT-P-deficient mice. (A, B) Soluble fractions prepared from 2- and 6-week-old mouse brains (WT
and GlcAT-P-deficient mice) were treated with chABCwith or without PNGase F, subjected to SDS-PAGE and then blotted using anti-HNK-1 mAb, 6B4 mAb,
Cat-315 mAb, phosphacan pAb and aggrecan pAb. To compare the molecular weight of HNK-1 immunoreactive band with aggrecan or phosphacan, an
HNK-1 mAb blot of 6-week-old PKOmice treated with chABC and PNGase F is shown on the right of the aggrecan panel. (C) Using urea-soluble fractions
from 6-week-old PKOmouse brains (input), aggrecan was immunoprecipitated using aggrecan pAb (IP: aggrecan) or normal rabbit IgG (IP: IgG). The
precipitated aggrecan was subjected to SDS-PAGE and western blotting with HNK-1, 6B4, Cat-315 and aggrecan antibodies.
doi:10.1371/journal.pone.0144560.g002
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panel, lane 12). These results indicate that aggrecan is the HNK-1 carrier protein in the
6-week-old PKO mouse brains.
To further confirm this assumption, we immunoprecipitated aggrecan from brain urea solu-
ble fractions of 6-week-old PKO mice and then immunoblotted the precipitated aggrecan
using HNK-1, 6B4, Cat-315 and anti-aggrecan antibodies. All three HNK-1 recognizing mAbs
reacted with immunoprecipitated aggrecan; slightly higher reactivity with 6B4 and Cat-315
than HNK-1 mAb (Fig 2C) was observed, which was similar to the PKO soluble fraction (Fig
2A). Based on these results and the findings from other groups [26, 39, 40], in the 6-week-old
mouse brain, we concluded that aggrecan was the carrier CSPG for the unique type of HNK-1
epitope generated in a GlcAT-P-independent manner.
A unique HNK-1 epitope on aggrecan is located in PNNs
Next, to examine whether the HNK-1 epitope on aggrecan was located in PNNs in mature
PKO brains, 6-week-old mouse brain sections were immunostained using HNK-1, 6B4 or Cat-
315 and anti-aggrecan antibodies. As we reported previously [31], PKOmice showed an overall
reduced HNK-1 reactivity, but the HNK-1 signals in PNN-like pattern almost completely
remained in the PKO brains (compare Fig 3A and 3D). The remaining HNK-1 epitope in the
PKO brain was largely colocalized with aggrecan (Fig 3D–3F) and high magnification showed
the colocalization in a typical PNN pattern (Fig 3F, inset). Staining of PKO sections with 6B4
and Cat-315 mAbs also showed the similar overlapped signals with aggrecan in PNN patterns
(Fig 3G–3L). Furthermore, PNNs were clearly detected with 6B4 and Cat-315 mAbs compared
with HNK-1 mAb, even in WT mouse brain sections (Fig 3A–3C), indicating that these two
mAbs preferentially recognize the unique HNK-1 epitope in PNNs. Taken together, these
results further confirmed that the HNK-1 epitope on aggrecan in PNNs is biosynthesized by an
unknown pathway independent of GlcAT-P.
HNK-1 epitope is synthesized by a novel glucuronyltransferase
Other than GlcAT-P, only one glucuronyltransferase, GlcAT-S, has been shown to biosynthe-
size the typical HNK-1 structure, HSO3-3GlcAβ1-3Galβ1-4GlcNAc-R [29]. To investigate
whether the HNK-1 epitope in PNNs is biosynthesized by GlcAT-S, we generated GlcAT-S
gene-deficient (SKO) mice as described inMaterials and Methods. Briefly, construction of the
targeting vector is schematically represented in Fig 1A. Eight ES clones among 356 tested
showed the desired homologous recombination (Fig 1B). Two lines of SKO mice were gener-
ated from two independent ES clones. The heterozygotes were further backcrossed with
C57BL/6 mice for more than 10 generations. The SKOmice were viable and fertile and their
brains showed no obvious abnormalities (data not shown). As we reported previously, GlcAT-S
is expressed in mouse kidney and the brain and is responsible for the non-sulfated HNK-1 car-
bohydrate in the kidney [44]. These non-sulfated HNK-1 carbohydrates detected with M6749
mAb, disappeared in the SKO kidney (Fig 1C).
Next, the PKO and SKOmice were interbred to obtain double-knockout (DKO) mice. DKO
mice were also viable and fertile. Brain soluble fractions from 6-week-old PKO and DKOmice
were subjected to glycosidase digestion and western blot analyses. Reactivity with HNK-1 in
DKOmice was not reduced compared with PKO mice (Fig 4A, HNK-1 panel). The molecular
weight of the HNK-1 reactive band in DKOmice was also consistent with aggrecan rather than
phosphacan (Fig 4A, aggrecan and phosphacan panels). In addition, the reactive band was
detected using 6B4 and Cat-315 mAbs in the DKOmice (Fig 4A, 6B4 and Cat-315 panels); the
DKO and PKO mice showed similar results. The effect of PNGase F digestion and the amounts
of loaded proteins were confirmed by immunoreactive bands with H28 (anti-NCAMmAb)
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and anti-actin mAb, respectively (Fig 4A,H28 and actin panels). These results indicate that
aggrecan is the HNK-1 carrier protein in the 6-week-old DKOmouse brain. To further confirm
this assumption, we immunoprecipitated aggrecan and phosphacan from brain soluble frac-
tions of 6-week-old DKO mice and then immunoblotted the precipitated aggrecan and phos-
phacan using HNK-1, anti-aggrecan and anti-phosphacan antibodies. HNK-1 reactivity was
observed on immunoprecipitated aggrecan but not on phosphacan (Fig 4B). Double-staining
of brain sections with HNK-1, 6B4 or Cat-315 mAb andWFA lectin also showed the remaining
HNK-1 reactivity in the PNNs of DKO mice (Fig 4F–4N), which was similar to PKO mice (Fig
3D, 3G and 3J and Fig 4C–4E). These results suggested a novel glucuronyltransferase, but nei-
ther GlcAT-P nor -S, was responsible for biosynthesis of the HNK-1 epitope in PNNs.
Fig 3. HNK-1 carbohydrate and aggrecan are expressed in the PNNs. Sagittal sections of cerebral cortex
from 6-week-old WT (A-C) and PKOmice (D-L) were singly (for WT) or doubly (for PKO) immunostained with
HNK-1 mAb (A, D), 6B4 mAb (B, G), or Cat-315 mAb (C, J), and aggrecan pAb (E, H, K). F, I and L are
overlaid images. High magnification images of HNK-1-, 6B4- or Cat-315- and aggrecan-positive PNNs are
shown in the insets. Scale bars, 200 μm (A-C), 100 μm (D-L) and 20 μm (insets).
doi:10.1371/journal.pone.0144560.g003
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HNK-1ST is involved in HNK-1 synthesis in COS-1 cells
A possible glucuronyltransferase for biosynthesis of the HNK-1 epitope in PNNs is GlcAT-I
that biosynthesizes glycosaminoglycans (GAGs) but displays extremely high homology to
GlcAT-P (42.7% identity) [45]. GlcAT-I is the sole enzyme responsible for GlcA transfer for
biosynthesis of the core tetrasaccharide structure of GAG, GlcAβ1-3Galβ1-3Galβ1-4Xyl, the
so-called linkage region [46, 47]. Previous reports showed that overexpression of GlcAT-I elic-
its HNK-1 immunoreactivity [46] and HNK-1ST can act on the GAG linkage to suppress GAG
elongation of thrombomodulin [48]. Based on these results, we assumed that GlcAT-I, working
with HNK-1ST, was the most feasible candidate for biosynthesis of the HNK-1 epitope on
aggrecan in the PNNs. To confirm this assumption, Fc-tagged short-form aggrecan (Fig 5A)
was transiently expressed with or without HNK-1ST in COS-1 cells in which endogenous
Fig 4. HNK-1 carbohydrate expressed in PKO and DKOmice. (A) Soluble fractions from 6-week-old GlcAT-P-deficient mice (PKO) and GlcAT-P and -S
double deficient mice (DKO) were treated with chABC and PNGase F, subjected to SDS-PAGE and blotted using HNK-1 mAb, 6B4 mAb, Cat-315 mAb,
aggrecan pAb, phosphacan pAb, H28 (NCAMmAb) or actin mAb. The effect of PNGase F treatment was confirmed by western blotting with H28 mAb. Actin
was used as the loading control. (B) Using soluble fractions from 6-week-old DKOmouse brains (input), aggrecan and phosphacan were immunoprecipitated
with aggrecan pAb (IP: aggrecan), normal rabbit IgG (IP: IgG) or phosphacan pAb (IP: phosphacan). The precipitated aggrecan and phosphacan were
subjected to SDS-PAGE and western blotting with HNK-1, aggrecan and phosphacan antibodies. (C-N) Sagittal sections of cerebral cortex from 6-week-old
PKO (C-E) and DKOmice (F-N) were double-immunostained with HNK-1 mAb, 6B4 mAb or Cat-315 mAb (red) andWFA lectin (green). Scale bar, 100 μm.
doi:10.1371/journal.pone.0144560.g004
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GlcAT-I but neither GlcAT-P nor GlcAT-S was expressed. Aggrecan-Fc was purified using
Protein G Sepharose from culture medium and subjected to western blot analysis. When aggre-
can-Fc was expressed alone, aggrecan-Fc was detected with anti-Fc antibody as a smear band
over 300 kDa (Fig 5B anti-Fc panel, lane 1). When co-expressed with HNK-1ST, the level of
the upper smear band of aggrecan-Fc was relatively reduced and instead a sharp lower band
became prominent (Fig 5B, anti-Fc panel, lane 3). The upper smear band converged at the
lower sharp band with chABC treatment (Fig 5B, anti-Fc panel, lanes 2 and 4), indicating the
lower sharp band was a non-CS-bearing aggrecan. More importantly, the non-CS-bearing
lower band was HNK-1-positive in an HNK-1ST dependent manner (Fig 5B, HNK-1 panel,
lane 3). The reactivity with HNK-1 mAb was unaffected with PNGase F treatment (data not
shown), which was consistent with the results in the PKO mouse brain (Fig 2). These results
suggest the possibility that the unique HNK-1 epitope on aggrecan is synthesized by stepwise
actions of GlcAT-I and HNK-1ST to create a unique sulfated type of GAG linkage region,
HSO3-GlcAβ1-3Galβ1-3Galβ1-4Xyl.
Notably, the relative increase in the level of the non-CS-bearing lower band of aggrecan
with HNK-1ST expression in Fig 5B suggests the addition of the HNK-1 epitope on aggrecan
downregulates its CS chain biosynthesis. This was also supported by weaker immunoreactivi-
ties with anti-CS antibodies of aggrecan (CS56 and IIH6) in the presence of overexpressed
HNK-1ST (Fig 5B, CS56 and IIH6 panels, lanes 3). Quantification of the signal intensities in
these blots revealed that CS56- and IIH6-immunoreactive signals of aggrecan-Fc in the pres-
ence of HNK-1ST were reduced to 40% and 44%, respectively, compared to those in the
Fig 5. Expression of a novel HNK-1 epitope on aggrecan in COS-1 cells. (A) Schematic diagram of the
Fc-tagged short aggrecan used in this study. (B) Aggrecan-Fc with or without HNK-1ST was heterologously
expressed into COS-1 cells. Aggrecan-Fc in the culture medium was purified using a Protein G Sepharose
column and digested with 100 μU/ml chABC and then blotted with anti-Fc pAb, HNK-1 mAb and anti-CS
antibodies (CS56 and clone IIH6). (C) Aggrecan-Fc and/or phosphacan-myc-Fc were transiently expressed
with HNK-1ST-EGFP into COS-1 cells. Aggrecan-Fc and phosphacan-myc-Fc in the culture medium were
precipitated with ethanol and digested with 200 μU/ml chABC, subjected to SDS-PAGE and then blotted with
anti-Fc pAb, HNK-1 mAb, aggrecan pAb and phosphacan pAb.
doi:10.1371/journal.pone.0144560.g005
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absence of HNK-1ST. In addition, we carried out a quantitative analysis of CS side chains
using high-performance liquid chromatography. Recombinant aggrecan-Fc was expressed
with or without HNK-1ST in COS-1 cells and purified from culture media. CS chains were pre-
pared from the recombinant aggrecan-Fc by chABC treatment, and the amount and composi-
tion of CS-derived disaccharides were analyzed. While the disaccharide unit composition was
unaffected, the total amount of CS on the aggrecan-Fc was decreased in the presence of HNK-
1ST and the quantity ratio (ST(+)/ST(-) ratio) was similar to the value in the western blot anal-
ysis (Table 1). These results suggest that the synthesis of the HNK-1 epitope on the GAG link-
age region inhibits its CS polymerization.
As shown in Fig 4B, the HNK-1 epitope in PNNs was specifically expressed on aggrecan but
not on phosphacan. To examine whether this specific HNK-1 expression is also observed in
COS-1 cells, phosphacan-myc-Fc and/or aggrecan-Fc were transiently expressed with HNK-
1ST. As shown in Fig 5C, HNK-1 immunoreactivity was not detected on phosphacan-myc-Fc
but on the aggrecan-Fc. This result implies that HNK-1ST preferentially recognizes aggrecan
as an acceptor rather than phosphacan, but the mechanism underlying this protein-selective
modification is unclear at present.
Identification of the glycan structure of the HNK-1 epitope on aggrecan
To further confirm that the sulfated linkage region is synthesized on aggrecan, aggrecan-Fc
was co-expressed with HNK-1ST and purified from COS-1 cells. HNK-1-positive aggrecan was
treated with chABC and PNGase F and then released O-glycans were PA-labeled and analyzed
using LC/MSn. Fig 6A upper panel shows the base peak chromatogram obtained using SIM
(m/z 782.5–832.5) in the negative ion mode. The major precursor ions in the mass spectra were
automatically subjected to data-dependent collision-induced dissociation-MS/MS and MS/MS/
MS. The extracted ion chromatogram (EIC) fromm/z 807.0 to 807.4 is shown in Fig 6A lower
panel. The singly charged ion (m/z 807.2) corresponding to PA-labeled HSO3-GlcA-Gal-Gal-
Xyl was detected in Peak A of the EIC. In the MS/MS spectrum of this ion, the product ion at
m/z 727.2 corresponded to [M-H-S]- and the ion atm/z 254.9 corresponded to B1
- (Fig 6B,
upper panel). In the MS/MS/MS spectrum acquired from product ion (m/z 727.2) in the MS/




tively. The ions atm/z 499.2 and 337.0 corresponded to [B3-S]
- and [B2-S]
-, respectively. These
results indicated the sulfate group was attached to the HexA-Hex-Hex-Xyl and most likely to
HexA. From these results, we concluded the sulfated tetrasaccharide, HSO3-GlcA-Gal-Gal-Xyl,
was expressed on aggrecan-Fc, the probable HNK-1 epitope expressed on aggrecan in PNNs.
Table 1. Quantification of chondroitin sulfate on the purified recombinant aggrecan-Fc.
aggrecan-Fc unsaturated disaccharide [pmol/ml]
ΔDi-0S ΔDi-6S ΔDi-4S Total
HNK-1ST(-) 120.9 145.5 318.4 584.8
HNK-1ST(+) 51.5 65.3 132.8 249.6
ST(+) / ST(-) ratio (%) 43% 45% 42% 43%
The puriﬁed recombinant aggrecan-Fc expressed with or without HNK-1ST was digested with chABC. The
digests were derivatized with a ﬂuorophore, 2-aminobenzamide, and then analyzed by anion-exchange
high-performance liquid chromatography. Each value was normalized by the amount of aggrecan-Fc. ΔDi-
0S, Δ4,5HexUAα1-3GalNAc; ΔDi-6S, Δ4,5HexUAα1-3GalNAc (6-O-sulfate); ΔDi-4S, Δ4,5HexUAα1-3GalNAc
(4-O-sulfate). The lowest row shows the quantity ratio of chondroitin sulfate on aggrecan-Fc with or without
HNK-1ST expression.
doi:10.1371/journal.pone.0144560.t001
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Discussion
In this study, by analyzing double knockout mice for GlcAT-P (B3gat1) and GlcAT-S (B3gat2)
both of which are involved in the canonical HNK-1 biosynthesis, we demonstrated that a
unique HNK-1 structure is expressed on aggrecan in PNNs. Using COS-1 cells in which neither
GlcAT-P nor GlcAT-S is expressed, we identified the unique HNK-1 epitope as a sulfated type
of GAG linkage region synthesized on aggrecan in an HNK-1ST dependent manner. Therefore,
we named this structure a linkage type HNK-1 epitope to be distinguished from classical
HNK-1. Furthermore, expression of such unique HNK-1 epitope on aggrecan suppresses its
CS biosynthesis (Fig 7).
To date, the HNK-1 epitope has been shown to be expressed on N-linked glycans or O-man-
nosylated glycans in the CNS [32, 42, 43, 49] and 6B4 and Cat-315 mAbs, which are widely
Fig 6. LC/MSn structural analysis of HNK-1 epitope on aggrecan. (A) PA-labeledO-linked glycans were prepared from aggrecan-Fc co-expressed with
HNK-1ST in COS-1 cells. The base peak chromatogram of the glycans was obtained using selected ion monitoring (SIM) (m/z 782.5–832.5) in the negative
ion mode (upper panel). An extracted ion chromatogram (EIC) of the ion atm/z 807.0–807.4 (lower panel). (B) MS/MS spectra (upper panel) of the ion [M-H]-
(m/z 807.2) detected in peak A and MS/MS/MS spectra (lower panel) of the predominant product ion (m/z 727.2) in the MS/MS. S, sulfate group; HexA,
hexuronic acid; Hex, hexose; Xyl-PA, xylose labeled with 2-aminopyridine.
doi:10.1371/journal.pone.0144560.g006
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used to stain PNNs, were believed to recognize the N-linked or O-mannosylated types of
HNK-1 epitopes [37, 39, 40, 41]. In the present study, we demonstrated that a third type of
HNK-1 epitope is expressed on the GAG linkage region of aggrecan after formation of PNNs
and 6B4 and Cat-315 mAbs have higher specificity for that type of HNK-1 epitope (Fig 2).
Considering the reactivity of these mAbs to O-mannosylated type of HNK-1 in the developing
brain [37, 39, 40, 41] (Fig 2A), epitopes of 6B4 and Cat-315 mAbs are likely switched during
development from O-mannosylated HNK-1 on phosphacan to the linkage region type of
HNK-1 on aggrecan. Several antibodies recognize the HNK-1 epitope [24–26]; however, we
suggest that 6B4 and Cat-315 are better probes than HNK-1 mAb to detect the linkage type
HNK-1 epitope in PNNs (Fig 3A, 3B and 3C). Recently, the serum of peripheral neuropathy
patients having 6B4 or Cat-315 type autoantibodies showed higher treatment resistance than
patients with general type of HNK-1 autoantibodies [50]. Difference in specificity of HNK-
1-related mAbs could be a good indicator for severity of demyelinating diseases.
PNNs are expressed around GABAergic interneurons, especially parvalbumin expressing
cells [10, 11, 13]. GABAergic interneurons are highly heterogeneous [51]. For example, more
than 20 classes of interneurons have been identified in the hippocampus and neocortex, each
with distinctive spatial and temporal capabilities to influence cortical circuits [52, 53]. HNK-1
positive PNNs largely colocalized with aggrecan or WFA but PNNs expressing aggrecan or
WFA were not always HNK-1-positive (Figs 3D–3L and 4C–4N), indicating that expression of
the linkage type HNK-1 epitope is distinctly regulated around a subset of neurons. In addition,
the number of Cat-315-positive PNNs changes in an activity-dependent manner in the rat
superior olivary complex and the mouse barrel cortex [21, 54], and 6B4 and Cat-315-positive
PNNs were prominently reduced in the age-dependent neurodegeneration model mouse brain
[55]. These findings suggest that the linkage type HNK-1 epitope in PNNs is functionally
involved in neural plasticity. Therefore, to better understand the role of HNK-1 in PNNs, iden-
tifying the cell types among the GABAergic interneurons that express this epitope is
important.
Fig 7. Biosynthetic model for HNK-1 epitope on aggrecan in PNNs.GlcAT-I is responsible for synthesis
of a linkage region of GAG, which is usually further elongated into a long GAG chain (e.g., CS chain). HNK-
1ST transfers a sulfate group to GlcA of the linkage region of aggrecan, which likely results in the expression
of the linkage type HNK-1 epitope, HSO3-GlcA-Gal-Gal-Xyl, in PNNs. The expression of the HNK-1 epitope
on aggrecan suppresses the CS polymerization that starts from GlcA of the linkage region.
doi:10.1371/journal.pone.0144560.g007
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Our structural analysis suggests that GlcAT-I, the sole enzyme identified for synthesis of the
GAG linkage region to date, might be involved in the linkage type HNK-1 epitope on aggrecan
in PNNs. Previous findings showing overexpression of GlcAT-I evoked HNK-1 immunoreac-
tivity [46] and the sulfated linkage region was detected in human urine [56, 57] further sup-
ports our hypothesis that GlcAT-I is the enzyme responsible for the synthesis of the unusual
HNK-1 on aggrecan. However, directly demonstrating its involvement is difficult because
GlcAT-I (B3gat3)-knockout mice show embryonic lethality at a very early stage [58]. In addi-
tion, it is also difficult to demonstrate the contribution of GlcAT-I by its knockdown targeting
to PNN-forming interneurons because the HNK-1 epitope is expressed in a subpopulation of
PNN-forming interneurons, which would make it hard to distinguish the signal reduction in
HNK-1 by GlcAT-I silencing from the original feature as a non-HNK-1-expressing PNN.
We also demonstrated that heterologous expression of HNK-1ST is required for synthesis
of the linkage type HNK-1 epitope. Recently, it was shown that HNK-1ST can transfer a sulfate
group to steroid hormones to regulate estrogen signaling [59]. Furthermore, we reported that
HNK-1ST negatively regulates biosynthesis of O-mannosylated laminin-binding glycan essen-
tial for muscular functions [60]. These results indicate that HNK-1ST is a versatile enzyme and
transfers a sulfate group to more substrates than expected.
We showed that HNK-1ST suppressed CS biosynthesis by synthesizing a HNK-1 epitope on
the linkage region of aggrecan (Fig 5B and Table 1). Considering the importance of the CS
chain or its degree of sulfation for neural plasticity such as ocular dominance plasticity [16, 23,
61, 62], the linkage type HNK-1 epitope may indirectly regulate neural plasticity by reducing
the number of CS chains. In PNN-formed 6-week-old PKO or DKOmouse brains, even after
the linkage type HNK-1 epitope was expressed, aggrecan still showed the smear band pattern,
indicating that aggrecan possesses CS chains and simultaneously the linkage type HNK-1 epi-
tope. These results suggest that a limited number of CS chain attachment sites (i.e., several spe-
cific sites) on aggrecan are sulfated and negatively regulated by HNK-1ST. A recent report
showed that synthesis of the CS chain is regulated by phosphorylation of the Xyl residue in the
linkage region [63], thus phosphorylation of Xyl may help HNK-1ST recognize a linkage
region.
In conclusion, in the present study we discovered a new aspect of the HNK-1 epitope. These
results shed light on the distinct in vivo roles of three homologous glucuronyltransferases
(GlcAT-P, -S, -I) for HNK-1 synthesis. Further studies should aim to clarify how the linkage
type HNK-1 epitope is involved in neural plasticity and GAG synthesis in PNNs in the brain.
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